SCOLLO, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 5.015
EU - Europa 2.603
AS - Asia 1.919
SA - Sud America 531
AF - Africa 49
OC - Oceania 3
Totale 10.120
Nazione #
US - Stati Uniti d'America 4.948
IE - Irlanda 1.757
SG - Singapore 892
HK - Hong Kong 615
BR - Brasile 468
IT - Italia 279
GB - Regno Unito 191
DE - Germania 125
VN - Vietnam 97
CN - Cina 76
FI - Finlandia 68
TR - Turchia 59
FR - Francia 56
IN - India 38
BD - Bangladesh 31
CA - Canada 28
AR - Argentina 24
CZ - Repubblica Ceca 22
CH - Svizzera 21
MX - Messico 21
ZA - Sudafrica 19
AT - Austria 15
JP - Giappone 14
PL - Polonia 14
IQ - Iraq 13
KR - Corea 12
RU - Federazione Russa 10
ID - Indonesia 9
PK - Pakistan 9
VE - Venezuela 9
CO - Colombia 8
EC - Ecuador 8
MA - Marocco 8
SE - Svezia 8
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
AG - Antigua e Barbuda 6
EG - Egitto 6
KE - Kenya 6
PE - Perù 6
RO - Romania 6
SA - Arabia Saudita 5
UA - Ucraina 5
ES - Italia 4
IL - Israele 4
JO - Giordania 4
LA - Repubblica Popolare Democratica del Laos 4
NL - Olanda 4
CL - Cile 3
GT - Guatemala 3
HN - Honduras 3
IR - Iran 3
KZ - Kazakistan 3
LB - Libano 3
LT - Lituania 3
NP - Nepal 3
PY - Paraguay 3
TN - Tunisia 3
AU - Australia 2
AZ - Azerbaigian 2
BE - Belgio 2
BN - Brunei Darussalam 2
CR - Costa Rica 2
LK - Sri Lanka 2
LU - Lussemburgo 2
LV - Lettonia 2
NO - Norvegia 2
RS - Serbia 2
SN - Senegal 2
TH - Thailandia 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
DO - Repubblica Dominicana 1
GM - Gambi 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
LY - Libia 1
NG - Nigeria 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SV - El Salvador 1
TO - Tonga 1
TT - Trinidad e Tobago 1
UG - Uganda 1
Totale 10.120
Città #
Dallas 3.688
Dublin 1.743
Hong Kong 614
Singapore 420
Boardman 352
Santa Clara 166
The Dalles 165
London 150
Milan 117
Ashburn 97
Los Angeles 71
Helsinki 66
Istanbul 46
Ho Chi Minh City 43
Seattle 34
São Paulo 34
Catania 31
Munich 30
Assago 22
Frankfurt am Main 21
Zurich 21
Beijing 18
Brno 18
Hanoi 18
Brooklyn 16
Düsseldorf 16
Palermo 16
Council Bluffs 14
Rio de Janeiro 14
Rome 14
Campinas 12
Warsaw 12
Belo Horizonte 11
Brasília 11
Johannesburg 11
San Francisco 11
Curitiba 10
Seoul 10
Tokyo 10
Mexico City 9
New York 9
Chennai 8
Dhaka 8
West Jordan 8
Misterbianco 7
San Jose 7
Stockholm 7
Tashkent 7
Atlanta 6
Guangzhou 6
Haiphong 6
Manchester 6
Portsmouth 6
St John's 6
Thái Bình 6
Vienna 6
Columbus 5
Falkenstein 5
Fortaleza 5
Goiânia 5
Maracaibo 5
Montreal 5
Nairobi 5
Phoenix 5
Roubaix 5
Sorocaba 5
Toronto 5
Alessandria 4
Amman 4
Ankara 4
Boston 4
Chicago 4
Erbil 4
Guayaquil 4
Mumbai 4
Nanyang 4
New Delhi 4
Ninh Bình 4
Nuremberg 4
Ottawa 4
Pianopoli 4
Porto Alegre 4
Ribeirão das Neves 4
Rio Branco 4
Salvador 4
Santo André 4
Vientiane 4
Vila Velha 4
Washington 4
Aparecida de Goiânia 3
Baghdad 3
Betim 3
Bexley 3
Birigui 3
Bogotá 3
Buenos Aires 3
Buffalo 3
Cabo Frio 3
Cairo 3
Campo Grande 3
Totale 8.467
Nome #
The role of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer 554
Medical Comorbidities in Alzheimer's Disease: An Autopsy Confirmed Study with a Focus on Sex-Differences? 537
Feasibility and safety of robotic single-port surgical staging in epithelial ovarian cancer using the da Vinci SP platform: a preliminary experience 520
Endometrial carcinosarcoma without myoinvasion 492
Management of ocular toxicity in patients with gynecologic cancer receiving novel antibody–drug conjugates: a narrative review 218
Exploit the γ-Glutamyl hydroxymethyl rhodamine green fluorescence in surgical resection: A systematic literature review on clinical indications, fields of application and outcomes 111
Uterosacral Ligament Suspension Sec Shull by Vaginal Natural Transluminal Endoscopic Surgery (vNOTES) 98
[Peritonectomy and hyperthermic chemoperfusion in peritoneal carcinomatosis. Preliminary results] 91
Bevacizumab, carboplatin, and paclitaxel in the first line treatment of advanced ovarian cancer patients: the phase IV MITO-16A/MaNGO-OV2A study 90
Advancing Glaucoma Treatment During Pregnancy and Breastfeeding: Contemporary Management Strategies and Prospective Therapeutic Developments 86
1st Evidence-based Italian consensus conference on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinosis from ovarian cancer 86
A retrospective, real-life analysis of metronomic oral single-agent cyclophosphamide for the treatment of platinum-pretreated advanced ovarian carcinoma in Italy 85
A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: The @RISTOS Project 84
#534 Prognosis of surgically staged FIGO IA uterine carcinosarcoma without myometrial invasion: a multicenter international retrospective cohort study 78
A phase 2 multicenter study of irinotecan and cisplatinum as neoadjuvant treatment in patients with locally advanced cervical cancer 77
Unraveling the complexity of HRD assessment in ovarian cancer by combining genomic and functional approaches: translational analyses of MITO16-MaNGO-OV-2 trial 76
First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial 76
Machine Learning Application Identifies Germline Markers of Hypertension in Patients With Ovarian Cancer Treated With Carboplatin, Taxane, and Bevacizumab 75
A multidisciplinary approach remains the best strategy to improve and strengthen the management of ovarian cancer 74
Adnexal Torsion in Pediatric Age: Does Bolli's Score Work? Report of Two Cases. 72
Efficacy and safety of neoadjuvant paclitaxel, ifosfamide, and cisplatin (TIP) chemotherapy in locally advanced squamous cell cervical carcinoma followed by radical surgery: A single institution experience 72
Azoospermic patient's treatment: An experience of a PMA hospital unit and role of ultrasonography 71
A very rare case of uterine PEComa HMB45 negative: primitive or relapse? 71
Knowledge and attitudes towards clinical trials among women with ovarian cancer: results of the ACTO study 70
Deceased Donor Uterus Transplantation: A Narrative Review of the First 24 Published Cases 69
A review and metanalysis of metronomic oral single-agent cyclophosphamide for treating advanced ovarian carcinoma in the era of precision medicine 69
Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: a retrospective MITO group study 68
Adhesions and pain in women with first diagnosis of endometriosis: Results from a cross-sectional study 68
Down-regulation of long non-coding RNAs in reproductive aging and analysis of the lncRNA-miRNA-mRNA networks in human cumulus cells 67
Anomalie di sede della gravidanza: la gravidanza ectopica e "unknown location" 67
Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: predictive value of DNA-PK and phosphorylated ACC 67
Psychological and personality assessment in patients candidates for Uterus Transplantation from deceased donor: preliminary results 66
Evaluation of Borderline Ovarian Tumor Recurrence Rate after Surgery with or without Fertility-Sparing Approach: Results of a Retrospective Analysis 65
A Circular RNA Derived from the Pumilio 1 Gene Could Regulate PTEN in Human Cumulus Cells 64
Dilatation and Curettage after Uterine Artery Embolization versus Methotrexate Injection for the Treatment of Cesarean Scar Pregnancy: A Single-Center Experience 62
Alcohol and pregnancy: What actually the women should know 61
Benign Multicystic Omental Mesothelioma in Pregnancy: A Case Report and Review of the Literature 60
Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer 59
Strategies for preventing group B streptococcal infections in newborns: A nation-wide survey of Italian policies 58
Paclitaxel/carboplatin versus topotecan/paclitaxel/carboplatin in patients with FIGO suboptimally resected stage III-IV epithelial ovarian cancer a multicenter, randomized study. 58
The apoptotic transcriptome of the human MII oocyte: characterization and age-related changes 58
Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19) 58
T cells in ovarian cancer. 58
Light and energy based therapeutics for genitourinary syndrome of menopause: Consensus and controversies 57
Efficacy and tolerability of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma 57
Management of cervical pregnancy: a diagnostic and therapeutic approach 55
The way a nose could affect pregnancy: severe and recurrent epistaxis. 55
Sacral agenesis: Case report [Agenesia del sacro: Case report] 55
Hysterectomy by transvaginal natural orifice transluminal endoscopic surgery: An Italian initial experience 54
Diminished ovarian reserve and ectopic ovaries in patients with Mayer-Rokitansky-Küster-Hauser syndrome candidates for Uterus Transplantation: our experience 54
Identification of extracellular vesicles and characterization of miRNA expression profiles in human blastocoel fluid 54
TAF4B is a molecular marker of oocyte quality 54
Relationship between stage, site and morphological characteristics of pelvic endometriosis and pain 53
Utilizzo del "Ligasure" nella isterectomia addominale: rapporto costi-benefici 53
Italian Journal Of Obstestrics & Gynaecology on web: A one-year balance 53
Polyglandular Autoimmune Syndrome in pregnancy: case report 53
Evaluation of pemetrexed (Alimta, LY231514) as second-line chemotherapy in persistent or recurrent carcinoma of the cervix: the CERVIX 1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group. 53
Early solitary splenic metastasis of endometrial cancer: a case report and review of literature 53
Frequenza e determinanti di complicanze tromboemboliche venose nelle pazienti sottoposte ad intervento chirurgico per una patologia neoplastica di interesse ginecologico 52
Is the endometrial evaluation routinely required in patients with adult granulosa cell tumors of the ovary? 52
Registry of the International Society of Uterus Transplantation: First Report 52
Recurrence of aggressive angiomyxoma of the vulva: a case report 51
Genetic screening in young women diagnosed with endometrial cancer 51
Safety and efficacy of new techniques of radiotherapy in oligometastatic recurrent ovarian cancer patients with BRCA1/2 mutation 51
The Interplay Between Sleep Apnea and Postpartum Depression 51
Mutational status of KRAS, NRAS, and BRAF in primary clear cell ovarian carcinoma 50
Colorectal endometriosis: aggressive surgical management and practical considerations in a patient with advanced disease. 50
Miomectomia laparoscopica intracapsulare versus non intracapsulare: studio prospettico con l'ecografia transvaginale 50
Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer: preliminary activity results of the MITO-2 phase III trial. 50
Safety and efficacy of new techniques of radiotherapy in oligometastatic recurrent ovarian cancer patients with BRCA1/2 mutation 50
Diagnosi ecografica delle malformazioni fetali. Malformazioni urinarie: possibilita' e limiti diagnostici 49
Serotonin and dopamine play complementary roles in gambling to recover losses. 49
Monitoring of the lower urinary tract function after radical Wertheim-Meigs hysterectomy 49
Patologia benigna dell'utero 49
High prevalence of thyroid dysfunction in pregnant women 49
Up-regulated microRNAs in blastocoel fluid of human implanted embryos could control circuits of pluripotency and be related to embryo competence 49
Molecular profiling of follicular fluid miRNAs in young women affected by Hodgkin Lymphoma 49
Cumulative Sum Analysis of Learning Curve Process for Vaginal Natural Orifice Transluminal Endoscopic Surgery Hysterectomy 49
Percutaneous-assisted laparoscopic bilateral salpingo-oophorectomy in BRCA-mutated patients: a retrospective comparative study 48
Obstructive Sleep Apnea in Pregnancy: A Comprehensive Review of Maternal and Fetal Implications 47
Identification of the novel BRCA1 c.2463_2464delTA mutation in two high grade serous ovarian cancer sisters and potential dosage effects implications: a case report 47
Extending the platinum-free interval with a non-platinum therapy in platinum-sensitive recurrent ovarian cancer. Results from the SOCRATES Retrospective Study. 47
Practice patterns and 90-day treatment-related morbidity in early-stage cervical cancer 47
Safety of a 3-weekly schedule of carboplatin pegylate liposomal doxorubicin as first line chemotherapy results in patients with ovarian cancer preliminary results of the MITO-2 randomized trial 47
Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study. 47
Urinary, Gastrointestinal, and Sexual Dysfunctions after Chemotherapy, Radiotherapy, Radical Surgery or Multimodal Treatment in Women with Locally Advanced Cervical Cancer: A Multicenter Retrospective Study 46
Laparoscopic surgery for isolated inguinal node relapse of high grade serous ovarian cancer using a bipolar combination instrument 46
Thromboembolic events and antithrombotic prophylaxis in advanced ovarian cancer patients treated with bevacizumab: secondary analysis of the phase IV MITO-16A/MaNGO-OV2A trial 46
Time without symptoms or toxicity in patients with recurrent ovarian cancer receiving niraparib maintenance treatment versus placebo: A TWIST analysis of the ENGOT24-OV16/NOVA trial 46
MicroRNAs upregulated in follicular fluid are carried by exosomes: new actors in the communication between oocyte and somatic follicular cells? 46
Evaluation of Ovarian Reserve and Recurrence Rate After DWLS Diode Laser Ovarian Endometrioma Vaporization (OMAlaser): A Prospective, Single-arm, Multicenter, Clinical Trial 46
Osteoporosis's Menopausal Epidemiological Risk Observation (O.M.E.R.O.) study 46
Hysteroscopic versus cervical injection for sentinel node detection in endometrial cancer: A multicenter prospective randomised controlled trial from the Multicenter Italian Trials in Ovarian cancer (MITO) study group 45
Effects of Deep Versus Moderate Neuromuscular Blockade in Laparoscopic Gynecologic Surgery on Postoperative Pain and Surgical Conditions: Protocol for a Randomized Controlled Trial.Effects of Deep Versus Moderate Neuromuscular Blockade in Laparoscopic Gynecologic Surgery on Postoperative Pain and Surgical Conditions: Protocol for a Randomized Controlled Trial 45
Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups 44
Position paper on prevention of surgical site infections in obstetric and gynecological surgery 44
Molecular characterization of exosomes and their microRNA cargo in human follicular fluid: bioinformatic analysis reveals that exosomal microRNAs control pathways involved in follicular maturation 44
MicroRNAs are stored in the human MII oocyte and their expression profile changes in reproductive aging 44
Randomized trial of neoadjuvant chemotherapy comparing paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (Studio Neo-Adjuvante Portio) Italian Collaborative Study. 44
Homologous Recombination Deficiency (HRD) Scoring, by Means of Two Different Shallow Whole-Genome Sequencing Pipelines (sWGS), in Ovarian Cancer Patients: A Comparison with Myriad MyChoice Assay 44
Totale 7.887
Categoria #
all - tutte 52.580
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.580


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202343 0 0 0 0 0 0 0 0 0 0 20 23
2023/20242.534 10 28 203 136 371 246 461 228 179 194 278 200
2024/20252.817 210 106 220 66 288 142 207 125 402 546 349 156
2025/20264.954 388 1.342 2.610 349 168 97 0 0 0 0 0 0
Totale 10.348